Impact of biologic therapy on functional status in patients with rheumatoid arthritis--a meta-analysis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of biologic therapy on functional status in patients with rheumatoid arthritis--a meta-analysis
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume 52, Issue 12, Pages 2127-2135
Publisher
Oxford University Press (OUP)
Online
2013-08-15
DOI
10.1093/rheumatology/ket266
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naïve patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study
- (2012) Jacqueline Detert et al. ANNALS OF THE RHEUMATIC DISEASES
- Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis
- (2012) Monika Schoels et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study
- (2012) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- Indirect Treatment Comparison of Abatacept with Methotrexate Versus Other Biologic Agents for Active Rheumatoid Arthritis Despite Methotrexate Therapy in the United Kingdom
- (2012) P. GUYOT et al. JOURNAL OF RHEUMATOLOGY
- Phase II dose–response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate
- (2012) Tsutomu Takeuchi et al. Modern Rheumatology
- Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study
- (2012) M. E. Weinblatt et al. RHEUMATOLOGY
- A mixed treatment comparison of the efficacy of anti-TNF agents in rheumatoid arthritis for methotrexate non-responders demonstrates differences between treatments: a Bayesian approach
- (2011) Susanne Schmitz et al. ANNALS OF THE RHEUMATIC DISEASES
- Golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis: results of the GO-FORTH study
- (2011) Yoshiya Tanaka et al. ANNALS OF THE RHEUMATIC DISEASES
- Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs
- (2011) Roy Fleischmann et al. ARTHRITIS AND RHEUMATISM
- A Dose–Response Meta-Analysis for Quantifying Relative Efficacy of Biologics in Rheumatoid Arthritis
- (2011) J W Mandema et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Mortality Risk by Functional Status and Health-related Quality of Life in Patients with Rheumatoid Arthritis
- (2011) K. MICHAUD et al. JOURNAL OF RHEUMATOLOGY
- Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis
- (2011) Patricia Guyot et al. ARTHRITIS RESEARCH & THERAPY
- Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study
- (2010) E. Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- Effectiveness of Biologic Therapies for Rheumatoid Arthritis: An Indirect Comparisons Approach
- (2010) Emily Beth Devine et al. PHARMACOTHERAPY
- Effect of rituximab on physical function and quality of life in patients with rheumatoid arthritis previously untreated with methotrexate
- (2010) William Rigby et al. ARTHRITIS CARE & RESEARCH
- Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors
- (2009) R Westhovens et al. ANNALS OF THE RHEUMATIC DISEASES
- Golimumab, a human anti-tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis
- (2009) Paul Emery et al. ARTHRITIS AND RHEUMATISM
- A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview
- (2009) J. A. Singh et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Randomized, Double-blind, Placebo-controlled, Comparative Study of Human Anti-TNF Antibody Adalimumab in Combination with Methotrexate and Methotrexate Alone in Taiwanese Patients with Active Rheumatoid Arthritis
- (2009) Der-Yuan Chen et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
- (2009) Josef S Smolen et al. LANCET
- Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial
- (2008) J Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti–tumor necrosis factor therapy
- (2008) E. Keystone et al. ARTHRITIS AND RHEUMATISM
- Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis
- (2008) Victoria Bejarano et al. ARTHRITIS AND RHEUMATISM
- Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
- (2008) Edward Keystone et al. ARTHRITIS AND RHEUMATISM
- Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial
- (2008) Paul Emery et al. LANCET
- Clinical investigation in highly disease-affected rheumatoid arthritis patients in Japan with adalimumab applying standard and general evaluation: the CHANGE study
- (2008) Nobuyuki Miyasaka et al. Modern Rheumatology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started